# Rocky Mountain Chocolate Factory, Inc.: overview RMCF · Nasdaq · CIK 1616262 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Feb 28 Pages: [Overview](/companies/rmcf.md) · [Financials](/companies/rmcf/financials.md) · [Filings](/companies/rmcf/filings.md) · [Insiders](/companies/rmcf/insiders.md) Latest reported revenue: [$6.7m](/filings/0001193125-26-425389.md) for Q2 FY2027, three months to 2026-08-31, from the 10-Q filed Oct 19, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-425389). ## Last eight quarters | Line item | Unit | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [7,893](/filings/0001193125-26-011914.md) | [8,899 d](/filings/0001193125-26-248296.md) | [6,373](/filings/0001193125-26-303159.md) | [6,823](/filings/0001193125-26-425389.md) | [7,543](/filings/0001193125-26-011914.md) | [6,758 d](/filings/0001193125-26-248296.md) | [6,113](/filings/0001193125-26-303159.md) | [6,652](/filings/0001193125-26-425389.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(8.9%)](/filings/0001193125-26-011914.md) | [(30.3%) d](/filings/0001193125-26-248296.md) | [(2.3%)](/filings/0001193125-26-303159.md) | [(7.0%)](/filings/0001193125-26-425389.md) | [1.1%](/filings/0001193125-26-011914.md) | [(45.1%) d](/filings/0001193125-26-248296.md) | [(16.5%)](/filings/0001193125-26-303159.md) | [(16.3%)](/filings/0001193125-26-425389.md) | | Net margin | % | [(10.7%)](/filings/0001193125-26-011914.md) | [(32.5%) d](/filings/0001193125-26-248296.md) | [(5.1%)](/filings/0001193125-26-425389.md) | [(9.7%)](/filings/0001193125-26-425389.md) | [(2.1%)](/filings/0001193125-26-011914.md) | [(50.6%) d](/filings/0001193125-26-248296.md) | [(19.1%)](/filings/0001193125-26-425389.md) | [(19.3%)](/filings/0001193125-26-425389.md) | | Diluted EPS | $ per share | [(0.11)](/filings/0001193125-26-011914.md) | not reported | [(0.04)](/filings/0001193125-26-303159.md) | [(0.09)](/filings/0001193125-26-425389.md) | [(0.02)](/filings/0001193125-26-011914.md) | not reported | [(0.12)](/filings/0001193125-26-303159.md) | [(0.14)](/filings/0001193125-26-425389.md) | | Free cash flow | $k | [(2,733) d](/filings/0001193125-26-011914.md) | [(420) d](/filings/0001193125-26-248296.md) | [182](/filings/0001193125-26-303159.md) | [(544) d](/filings/0001193125-26-425389.md) | [(1,278) d](/filings/0001193125-26-011914.md) | [(739) d](/filings/0001193125-26-248296.md) | [(604)](/filings/0001193125-26-303159.md) | [(168) d](/filings/0001193125-26-425389.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-02-28) | FY2023 (2023-02-28) | FY2024 (2024-02-29) | FY2025 (2025-02-28) | FY2026 (2026-02-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [29.5](/filings/0000950170-24-072997.md) | [30.4](/filings/0000950170-24-072997.md) | [28.0](/filings/0001193125-26-248296.md) | [29.6](/filings/0001193125-26-248296.md) | [27.5](/filings/0001193125-26-248296.md) | | Gross margin | % | [16.7%](/filings/0001437749-23-016104.md) | [13.1%](/filings/0001437749-23-016104.md) | not reported | not reported | not reported | | Operating margin | % | [(2.4%)](/filings/0000950170-24-072997.md) | [(16.1%)](/filings/0000950170-24-072997.md) | [(17.5%)](/filings/0001193125-26-248296.md) | [(20.1%)](/filings/0001193125-26-248296.md) | [(13.0%)](/filings/0001193125-26-248296.md) | | Net margin | % | [(1.2%)](/filings/0000950170-24-072997.md) | [(18.7%)](/filings/0000950170-24-072997.md) | [(14.9%)](/filings/0001193125-26-248296.md) | [(20.7%)](/filings/0001193125-26-248296.md) | [(16.6%)](/filings/0001193125-26-248296.md) | | Diluted EPS | $ per share | [(0.06)](/filings/0000950170-24-072997.md) | [(0.91)](/filings/0000950170-24-072997.md) | [(0.66)](/filings/0001193125-26-248296.md) | [(0.86)](/filings/0001193125-26-248296.md) | [(0.56)](/filings/0001193125-26-248296.md) | | Free cash flow | $m | [1.9](/filings/0000950170-24-072997.md) | [(3.1)](/filings/0000950170-24-072997.md) | [(5.5)](/filings/0001193125-26-248296.md) | [(10.4)](/filings/0001193125-26-248296.md) | [(2.4)](/filings/0001193125-26-248296.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rmcf/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $234.7k | 263,823 | | Reduced −17,095 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $73.0k | 82,104 | | Reduced −12,652 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $59.6k | 66,950 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $54.2k | 60,880 | | Reduced −8,369 | | [WEALTH ENHANCEMENT ADVISORY SERVICES, LLC](/funds/1632972.md) | 2026-06-30 | $37.9k | 33,576 | | New +33,576 | | [Leverty Financial Group, LLC](/funds/1908386.md) | 2026-06-30 | $35.9k | 40,371 | | Unchanged | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $29.9k | 33,607 | | New +33,607 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $27.2k | 30,507 | | Unchanged | | [Salvus Wealth Management, LLC](/funds/1809236.md) | 2026-06-30 | $21.0k | 23,567 | | Unchanged | | [Allworth Financial LP](/funds/1555170.md) | 2026-06-30 | $20.9k | 23,500 | | Unchanged | ## Recent filings [All 852 filings](/companies/rmcf/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-19 | 21:23 ET | [10-Q](/filings/0001193125-26-425389.md) | Quarterly report, period 2026-08-31 | 0001193125-26-425389 | | 2026-10-19 | 21:10 ET | [8-K](/filings/0001213900-26-110733.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-110733 | | 2026-10-06 | 20:15 ET | [8-K](/filings/0001213900-26-107214.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-107214 | | 2026-08-24 | 12:40 ET | [8-K](/filings/0001213900-26-092815.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-092815 | | 2026-08-12 | 23:36 ET | [8-K](/filings/0001213900-26-087922.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-087922 | | 2026-08-07 | 20:05 ET | [8-K](/filings/0001213900-26-086676.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-086676 | | 2026-07-14 | 21:24 ET | [8-K](/filings/0001213900-26-078026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-078026 | | 2026-07-14 | 20:05 ET | [10-Q](/filings/0001193125-26-303159.md) | Quarterly report, period 2026-05-31 | 0001193125-26-303159 | | 2026-07-14 | 21:54 ET | [8-K/A](/filings/0001213900-26-077680.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-077680 | | 2026-07-06 | 21:25 ET | [8-K](/filings/0001213900-26-075603.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-075603 | ## Latest annual report [Form 10-K for the fiscal year ended Feb 28, 2026](/filings/0001193125-26-248296.md), filed May 29, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1616262 - Tickers: RMCF - Exchange: Nasdaq - SIC code: 2060 Sugar & Confectionery Products - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.